LAS VEGAS—Restorative neurostimulation can result in clinically meaningful and durable outcomes in patients with refractory mechanical chronic low back pain, according to a long-term follow-up of the ReActiv8-B clinical trial.
Five-year longitudinal results found that the novel restorative treatment (ReActiv8; Mainstay Medical) was effective, durable and safe in this patient population, with nearly 80% of patients experiencing at least a 50% improvement from baseline in visual analog scale